Improving Access to Medicines – funding certainty for essential medicines safety

Page last updated: 08 May 2018

Improving Access to Medicines – funding certainty for essential medicines safety (PDF 126 KB)

The Government will increase its investment in new medicines by $2.4 billion. The Government will invest $120 million over four years in the National Prescribing Service MedicineWise (NPS) and National Return of Unwanted Medicines (NatRUM).

Why is this important?

This measure will ensure that health professionals and consumers continue to have free access to information to support the quality use and prescription of medicines, healthcare services and tests, and access to collection points to return expired and unwanted medicines. More than 5,000 children end up in hospitals due to medicines poisoning every year in Australia.

It will provide longer term funding certainty for the NPS and NatRUM to continue to provide these services.

Who will benefit?

All Australians will benefit from improvements in how health technologies, medicines and medical tests are prescribed and used, and from a medicines collection program that helps to prevent deliberate or accidental drug misuse in the community.

The four year funding agreements of more than $120 million will give NPS and NatRUM funding certainty and enable them to continue to deliver their important work in ensuring appropriate healthcare and safe use of medicines for the community.

How much will this cost?

More efficient delivery of services will lead to reduced costs of $40 million from 2018–19 to 2021–22.

In this section